PFA
Pettinga Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
17,745
-10,915
| -38% | -$905K | 0.32% | 50 |
|
|
2025
Q1 | $2.32M | Sell |
28,660
-245
| -0.8% | -$19.9K | 0.55% | 43 |
|
|
2024
Q4 | $2.6M | Buy |
28,905
+3,297
| +13% | +$297K | 0.59% | 40 |
|
|
2024
Q3 | $2.53M | Sell |
25,608
-1,025
| -4% | -$101K | 0.6% | 35 |
|
|
2024
Q2 | $2.47M | Buy |
26,633
+193
| +0.7% | +$17.9K | 0.62% | 36 |
|
|
2024
Q1 | $2.51M | Sell |
26,440
-405
| -2% | -$38.4K | 0.64% | 38 |
|
|
2023
Q4 | $2.4M | Buy |
26,845
+8,030
| +43% | +$717K | 0.64% | 39 |
|
|
2023
Q3 | $1.37M | Buy |
18,815
+475
| +3% | +$34.7K | 0.42% | 40 |
|
|
2023
Q2 | $1.53M | Sell |
18,340
-870
| -5% | -$72.4K | 0.45% | 38 |
|
|
2023
Q1 | $1.46M | Buy |
19,210
+960
| +5% | +$73.2K | 0.46% | 38 |
|
|
2022
Q4 | $1.51M | Sell |
18,250
-2,020
| -10% | -$168K | 0.49% | 39 |
|
|
2022
Q3 | $1.61M | Buy |
20,270
+3,295
| +19% | +$261K | 0.55% | 37 |
|
|
2022
Q2 | $1.26M | Buy |
16,975
+4,525
| +36% | +$336K | 0.38% | 45 |
|
|
2022
Q1 | $1.12M | Buy |
12,450
+1,985
| +19% | +$178K | 0.28% | 52 |
|
|
2021
Q4 | $1.17M | Buy |
10,465
+4,823
| +85% | +$540K | 0.28% | 54 |
|
|
2021
Q3 | $709K | Buy |
+5,642
| New | +$709K | 0.18% | 61 |
|
|
2020
Q2 | – | Sell |
-7,070
| Closed | -$548K | – | 85 |
|
|
2020
Q1 | $548K | Buy |
+7,070
| New | +$548K | 0.37% | 40 |
|
|
2019
Q4 | – | Sell |
-13,875
| Closed | -$1.06M | – | 93 |
|
|
2019
Q3 | $1.06M | Buy |
13,875
+10,325
| +291% | +$787K | 0.57% | 37 |
|
|
2019
Q2 | $311K | Buy |
+3,550
| New | +$311K | 0.16% | 75 |
|
|
2019
Q1 | – | Sell |
-9,000
| Closed | -$646K | – | 102 |
|
|
2018
Q4 | $646K | Buy |
+9,000
| New | +$646K | 0.42% | 37 |
|